MARATTO

preprint

Free and Bioavailable Vitamin D Moderately Predicts Total Vitamin D Status in Tuberculosis Patients and Household contacts

2024Open accessMakerere University

Abstract

<title>Abstract</title> Total vitamin D is considered a perfect index for assessment of vitamin D status, attributable to longer half-life. However the bioactive free and bioavailable vitamin D levels are available to the cell. This study aimed to compare and evaluate the accuracy of free and bioavailable vitamin D in defining total vitamin D status in Patients with Tuberculosis. This was a cross-sectional study among newly diagnosed active tuberculosis patients, latent tuberculosis individuals and individuals without TB infection. Total vitamin D was measured by electrochemiluminescence and free and bioavailable vitamin D was measured using ELISA. The diagnostic performance of free and bioavailable portion was 59.18% for sensitivity, 66.67% for specificity, and 63.0% for AUC. The kappa statistic was 1460 (P-value = 0.0759), in the deficient group. In insufficient, sensitivity was,56.9% specificity was 66.7%, and AUC was 61.8%. Kappa was 0.146, P = 0.07. Free and bioavailable vitamin D is a moderate indicator of vitamin D status. The study suggested that free and bioavailable vitamin D is not superior for defining total vitamin D status in TB, however it may be complementary. Further studies are needed to improve the definition of vitamin D status and its importance in immunity.

Research topics

  • Vitamin D Research Studies
  • Perfectionism, Procrastination, Anxiety Studies
  • Eating Disorders and Behaviors

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.21203/rs.3.rs-4745449/v1

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.